FDA’s Contradictory Decisions Related to the Delaney Clause

DSpace/Manakin Repository

FDA’s Contradictory Decisions Related to the Delaney Clause

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Klimko, Katheryn
dc.date.accessioned 2012-07-06T20:11:28Z
dc.date.issued 2011
dc.identifier.citation Katheryn Klimko, FDA’s Contradictory Decisions Related to the Delaney Clause (May 2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963872
dc.description.abstract This paper will focus on FDA regulation under the Delaney Clause, and particularly regulations that have led to contradictory results. It first will examine the history and basic requirements of the Delaney Clause. It next will discuss cancer: statistics regarding the frequency, types, and causes of cancer. Then it will examine some foods and food additives that have been associated with some level of carcinogenicity and how FDA has handled them. It will conclude by discussing the inherent problems that the Delaney Clause presents in establishing a uniform system of regulation and, finally, by proposing some potential alternative ways in which FDA might better use its power to help the public avoid excessive exposure to carcinogenic food substances. en_US
dash.license LAA
dc.subject.other Food and Drug Law en_US
dc.title FDA’s Contradictory Decisions Related to the Delaney Clause en_US
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T20:11:28Z

Files in this item

Files Size Format View
Klimko, Katheryn E.pdf 282.9Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters